(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

RECEPTORES DE ANTÍGENO CHIMÉRICOS ANTICLAUDINA 18.2 HUMANIZADOS E SEUS USOS

ArquivadaInvention PatentPCT · US2020024432

Application data

Number

112021016673

Type

Invention Patent

Filing

03/24/2020

Publication

10/13/2021

PCT

US2020024432

Progress at the INPI

  1. Filing03/24/20
  2. Publication10/13/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 03/24/2020 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 09/19/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

PHANES THERAPEUTICS, INC.

US

See this company's full portfolio

Inventors

H. J. (pessoa física)

US

H. Z. (pessoa física)

US

M. W. (pessoa física)

US

Technical data

Priority claims

US

62/825,955 · 03/29/2019

US

62/859,843 · 06/11/2019

US

62/896,758 · 09/06/2019

Abstract

RECEPTORES DE ANTÍGENO CHIMÉRICOS ANTICLAUDINA 18.2 HUMANIZADOS E SEUS USOS. A presente invenção refere-se a receptores de antígenos quiméricos (CARs) específicos para CLDN18.2, vetores que codificam o CAR para CLDN18.2, células hospedeiras recombinantes compreendendo o CAR para CLDN18.2 (CAR-Ts ou CAR-NKs) e métodos de uso de CAR-Ts ou CAR-NKs para tratar uma doença associada à expressão de CLDN18.2.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

09/19/2023

RPI 2750

Arquivamento - Art. 33 da LPI

#11.1

07/04/2023

RPI 2739

Notificação de entrada na fase nacional - PCT

#1.3

10/13/2021

RPI 2649

Alteração de dados cadastrais

#1.1

08/31/2021

RPI 2643

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.